SCHEMBL8340904

SCHEMBL8340904

CNC(=S)NC(=O)CN1CCC(N=S(=O)=O)C1c1ccc(C)cc1

nearest known ligand 0.33

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ TACR1 P25103 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340296 0.94 TACR1 (0.35) GAAUSP2DRD2DRD4DRD3
SCHEMBL8340133 0.89 TDP1 (0.37) GAAALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL8336415 0.77 SMN1; SMN2 (0.33) GAADRD2DRD4DRD3ALDH1A1
SCHEMBL8335504 0.67 TDP1 (0.35) GAADRD2DRD3ALDH1A1SMN1; SMN2
SCHEMBL8339395 0.66 TSHR (0.31) GAAALDH1A1RAB9AL3MBTL1KMT2A
SCHEMBL8335763 0.65 TSHR (0.35) ALDH1A1
SCHEMBL14873200 0.61 LMNA (0.57) GAAALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL8339931 0.61 TDP1 (0.48) ALDH1A1SMN1; SMN2RAB9ALMNAKMT2A
SCHEMBL8337202 0.60 HPGD (0.39) GAAALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL8335612 0.60 LMNA (0.40) GAAALDH1A1SMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback